Intraoperative brain tumor classification via laser-induced fluorescence spectroscopy and machine learning
Tanner J Zachem1,2, Jacob E Sperber1, Sully F Chen1
1Departments of1Neurosurgery.
Journal of Neurosurgery
|April 4, 2025
Summary
TumorID, a laser-based spectroscopy device, rapidly classifies brain tumor tissues like glioma and meningioma using machine learning. This technology aids surgeons in real-time decision-making for improved tumor resection and patient outcomes.
Area of Science:
- Neurosurgery
- Biomedical Engineering
- Spectroscopy
Background:
- Accurate intraoperative identification of brain tumor tissues and their borders is crucial for optimizing neurosurgical resection.
- Current methods may involve delays or tissue manipulation, impacting surgical workflow and patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of a novel, nondestructive laser-based endogenous fluorescence spectroscopy device, TumorID, for rapid intraoperative classification of brain tumor specimens.
- To assess the performance of a machine learning algorithm in differentiating glioma, meningioma, pituitary adenoma, and nonneoplastic brain tissue using TumorID data.
Main Methods:
- TumorID utilizes a 100-mW, 405-nm laser for rapid (0.5 seconds), dye-free, nondestructive ex vivo scanning of tissue specimens.
- A support vector machine algorithm was trained on data from 46 patients to classify tissue types.
- Statistical analysis involved generalized estimating equations focusing on fluorophore emission regions (NADH, FAD, porphyrins).
Main Results:
- The machine learning model achieved a high multiclass area under the receiver operating characteristic curve of 0.809 ± 0.002.
- Neutral porphyrins significantly contributed to the model's classification power (p < 0.001).
- The system demonstrated rapid and accurate classification of various pathologies and surrounding brain tissue.
Conclusions:
- The TumorID device shows promise for real-time intraoperative tissue diagnostics in neurosurgery.
- Its ability to rapidly differentiate pathologies can aid surgical decision-making and border delineation.
- This technology has the potential to enhance the completeness of tumor resection and improve patient outcomes.


